Correlation Between MAIA Biotechnology and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on MAIA Biotechnology and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Telix Pharmaceuticals.
Diversification Opportunities for MAIA Biotechnology and Telix Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between MAIA and Telix is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Telix Pharmaceuticals
Given the investment horizon of 90 days MAIA Biotechnology is expected to under-perform the Telix Pharmaceuticals. In addition to that, MAIA Biotechnology is 1.72 times more volatile than Telix Pharmaceuticals Limited. It trades about -0.01 of its total potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.18 per unit of volatility. If you would invest 1,406 in Telix Pharmaceuticals Limited on October 26, 2024 and sell it today you would earn a total of 318.00 from holding Telix Pharmaceuticals Limited or generate 22.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MAIA Biotechnology vs. Telix Pharmaceuticals Limited
Performance |
| Timeline |
| MAIA Biotechnology |
| Telix Pharmaceuticals |
MAIA Biotechnology and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Telix Pharmaceuticals
The main advantage of trading using opposite MAIA Biotechnology and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |